An operation that targets the nerves connected to the kidney has been found to significantly reduce blood pressure in patients with hypertension, according to the results of a clinical trial led in the UK by Queen Mary University of London and Barts Health NHS Trust, and supported by the National Institute for Health Research (NIHR).
If the findings are confirmed in more extensive clinical trials, the surgery could offer hope to patients with high blood pressure who do not respond to drugs, and are at increased risk of cardiovascular diseases, including stroke and heart attack.
The international clinical trial, carried out from 2017 to 2018 at St Bartholomew’s Hospital in the UK by the NIHRBarts Biomedical Research Centre, tested a one-hour operation called ‘renal denervation’, which uses ultrasound energy to disrupt the nerves between the kidneys and the brain that carry signals for controlling blood pressure.
Significant reduction in blood pressure
146 patients in the United States, France, Germany, the Netherlands, Belgium and the United Kingdom were randomised to receive either renal denervation or a ‘sham procedure’ – the surgical equivalent of a placebo. Patients also remained off blood pressure medications for two months unless specified blood pressure levels were exceeded.
After two months, the renal denervation group experienced an 8.5 mm Hg reduction in blood pressure, which was a 6.3 mm Hg greater reduction compared with the sham group.
More than 66 per cent of subjects treated with renal denervation demonstrated a 5 mm Hg or greater reduction in blood pressure, compared with 33 per cent in the sham group.
No major adverse events were reported in either group, and the blood pressure lowering effect of renal denervation was consistent across sex and ethnicity.
An alternative to lifelong medications
UK Principal Investigator Dr Melvin Lobo from Queen Mary’s William Harvey Research Institute and Barts Health NHS Trust said: “These results leave us clinicians in no doubt that this ultrasound-based therapy works to improve blood pressure control – at least in the short term. Further larger trials will be needed to confirm the efficacy and safety of the technology, but we hope that they could lead to renal denervation therapy being offered as an alternative to lifelong medications for hypertension.”
The study has limitations including the short follow-up time of two months. This was done for safety reasons to minimise the duration of patients being off antihypertensive medications. Longer follow-up of this trial and additional numbers of treated patients will be necessary to provide greater assurance of safety and to exclude rare adverse events.
The Latest on: Hypertension
[google_news title=”” keyword=”hypertension” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Hypertension
- New study suggests salty immune cells surrounding brain linked to hypertension-induced dementiaon December 4, 2023 at 2:10 pm
The response of immune system cells inside the protective covering surrounding the brain may contribute to the cognitive decline that can occur in a person with chronic high blood pressure, according ...
- South East has highest percentage of hypertension cases – Societyon December 4, 2023 at 10:01 am
The Nigerian Hypertension Society on Monday said the South-East geopolitical zone bears the highest burden of hypertension in the country.
- Findings highlight importance of early monitoring and management of hypertension during and after pregnancyon December 4, 2023 at 9:50 am
Hispanic/Latina women with a history of hypertensive disorders of pregnancy (HDP)—conditions marked by high blood pressure during pregnancy—are more likely to have abnormalities in their heart ...
- 'Salty' immune cells surrounding the brain linked to hypertension-induced dementiaon December 4, 2023 at 9:11 am
A study suggests that the response of immune system cells inside the protective covering surrounding the brain may contribute to the cognitive decline that can occur in a person with chronic high ...
- Hypertension: Can Salt Intake Increase Your Risk of Developing High Blood Pressure? Here’s All You Need to Knowon December 4, 2023 at 3:23 am
Excessive salt intake can lead to high blood pressure (hypertension), which stiffens and narrows the blood vessels.
- Genetics a Key Contributor to Sex Differences in Hypertensionon December 4, 2023 at 2:47 am
Researchers reviewed nationwide data encompassing more than 200,000 individuals from diverse racial and ethnic backgrounds to assess the role of genetics in the sex differences in hypertension in a ...
- Don't Go Undiagnosed with Hypertension; Here Are Some Ways to Control Iton December 4, 2023 at 1:51 am
Hypertension, often referred to as high blood pressure, stands as a prevalent yet stealthy adversary in today's lifestyle-driven health ..|News Track ...
- Cracking the code of hypertension treatment: Insights from WHO’s reporton December 4, 2023 at 12:00 am
Explore the issue of hypertension, the hidden health concern affecting millions, and the global health initiatives aiming to combat it.
- Hypertension Drugs Market revenue to reach USD 40 Billion by 2035, says Research Nesteron December 3, 2023 at 11:00 pm
New York , Dec. 04, 2023 (GLOBE NEWSWIRE) -- The global hypertension drugs market size is estimated to attain at 4% CAGR from 2023 to 2035. The market is expected to garner a revenue of USD 40 billion ...
via Bing News